Hot Stocks: Brokerage view on Mankind Pharma, Delhivery, Suzlon and ICICI Lombard

Brokerage firms have issued their recommendations on various companies. Motilal Oswal maintained a buy rating on ICICI Lombard with a target price of Rs 1550. Jefferies initiated a hold rating on Mankind Pharma with a target price of Rs 1830. Bernstein initiated an outperform rating on Delhivery with a target price of Rs 460. ICICI Securities initiated coverage on Suzlon with a buy rating and a target price of Rs 22. The firms cite factors such as industry growth, earnings potential, and market leadership in their recommendations.

More To Explore

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003